Tialma is a New York-based Financial Consulting Firm that specializes in delivering bespoke strategic and fractional CFO solutions to healthcare and life sciences companies. Their team of professionals collaborates with various organizations in the biotech, therapeutics, specialty pharma, diagnostics, medical devices, healthcare technology, and services sectors tailored to accelerate clients’ next value inflection through fundraising, business development, and operating finance milestones. This approach is aimed at dramatically increasing shareholder value. As of now, the company's focus lies within the Biotechnology industry. Founded in 2023, Tialma's unique positioning and service offerings cater to the specific needs of the healthcare and life sciences sector, promising significant potential for growth and value creation in the future. For more information, visit www.tialma.com.
There is no investment information
No recent news or press coverage available for Tialma.